McKesson Stock - Weekly sector check on US drug distributors

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 16:47 CET. Details in the imprint.

McKesson (US58155Q1031) remains one of the largest healthcare distributors in the US market. With no fresh corporate news from the company or regulators on Saturday, the focus turns to how the stock fits into the broader drug distribution sector and its long-term positioning.

How McKesson compares with peers

In the US drug distribution oligopoly, McKesson sits alongside Cencora and Cardinal Health as one of three dominant wholesalers by revenue. According to recent market data, McKesson stock closed around $750 per share this week, reflecting a market cap near $88 billion.

The peer group trades on moderate earnings multiples for a defensive sector, with McKesson at roughly 19 times trailing earnings, slightly above some competitors but supported by robust cash flows. This valuation places the stock squarely in the large-cap healthcare value and quality bucket.

Sector dynamics and long-term drivers

Drug distributors operate on thin operating margins, often low single digits, but high volumes across pharmaceuticals and medical products make the business cash-generative. Industry scale and logistics efficiency are key differentiators, particularly in negotiating with manufacturers and pharmacies.

For McKesson, long-term demand is anchored by demographic trends and rising prescription volumes, while regulatory pressure on drug pricing and reimbursement remains a structural risk. The company also leans on technology offerings and specialty distribution to defend margins against commoditization.

What the company sells

McKesson generates most of its revenue by distributing branded and generic prescription drugs, over-the-counter medications and medical-surgical supplies to pharmacies, hospitals and healthcare providers. It also offers pharmacy management software and specialty services for oncology and other complex therapies.

Where the stock trades today

McKesson shares (US58155Q1031) trade on the New York Stock Exchange at $750.63 as of 06/18/2026, 16:00 ET, according to recent exchange data, with an implied market capitalization of about $87.9 billion.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.